Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderick T Bronson

Showing results (201-210 of 319) with videos related to

Pageof 32
Sort By:
Cancer Research|October 12, 2011
Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formationJaime Acquaviva, Hyun Jung Jun, Julie Lessard, et al.
Cell|March 11, 2008
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersAndrea Ventura, Amanda G Young, Monte M Winslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
APC-dependent suppression of colon carcinogenesis by PPARgammaGeoffrey D Girnun, Wendy M Smith, Stavit Drori, et al.
Behavioural Brain Research|May 9, 2002
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependentKelly A Young, Melissa L Berry, Connie L Mahaffey, et al.
Cancer Research|August 20, 2014
Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneityKin-Hoe Chow, Dong-Mi Shin, Molly H Jenkins, et al.
The European Journal of Neuroscience|September 21, 2007
Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypesStephan Niemann, Hiroaki Kanki, Yasuyuki Fukui, et al.
Cell Reports. Medicine|June 16, 2026
Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade gliomaPurna Mukherjee, Jack Maurer, Sylwia A Stopka, et al.
Plos One|October 4, 2011
The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancerJatin Roper, Michael P Richardson, Wei Vivian Wang, et al.
Nature Communications|January 12, 2022
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cellsRupesh S Patel, Rodrigo Romero, Emma V Watson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2016
Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell TransplantationRaimon Duran-Struuck, Abraham J Matar, Rebecca L Crepeau, et al.
Pageof 32

Showing results (201-210 of 319) with videos related to

Sort By:
Pageof 32
Cancer Research|October 12, 2011
Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formationJaime Acquaviva, Hyun Jung Jun, Julie Lessard, et al.
Cell|March 11, 2008
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersAndrea Ventura, Amanda G Young, Monte M Winslow, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
APC-dependent suppression of colon carcinogenesis by PPARgammaGeoffrey D Girnun, Wendy M Smith, Stavit Drori, et al.
Behavioural Brain Research|May 9, 2002
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependentKelly A Young, Melissa L Berry, Connie L Mahaffey, et al.
Cancer Research|August 20, 2014
Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneityKin-Hoe Chow, Dong-Mi Shin, Molly H Jenkins, et al.
The European Journal of Neuroscience|September 21, 2007
Genetic ablation of NMDA receptor subunit NR3B in mouse reveals motoneuronal and nonmotoneuronal phenotypesStephan Niemann, Hiroaki Kanki, Yasuyuki Fukui, et al.
Cell Reports. Medicine|June 16, 2026
Ketogenic diet as a metabolic vehicle enhancing the therapeutic efficacy of mebendazole and devimistat in juvenile syngeneic high-grade gliomaPurna Mukherjee, Jack Maurer, Sylwia A Stopka, et al.
Plos One|October 4, 2011
The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancerJatin Roper, Michael P Richardson, Wei Vivian Wang, et al.
Nature Communications|January 12, 2022
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cellsRupesh S Patel, Rodrigo Romero, Emma V Watson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2016
Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell TransplantationRaimon Duran-Struuck, Abraham J Matar, Rebecca L Crepeau, et al.
Pageof 32